Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association.

Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE Jr, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC Jr, Wilson PW; American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council..

Circulation. 2009 May 5;119(17):2408-16. doi: 10.1161/CIRCULATIONAHA.109.192278. Epub 2009 Apr 13. Erratum in: Circulation. 2009 Jun 30;119(25):e606. Hong, Yuling [added].

2.

Criteria for scientific evaluation of novel markers: a perspective.

Moons KG.

Clin Chem. 2010 Apr;56(4):537-41. doi: 10.1373/clinchem.2009.134155. Epub 2010 Feb 4. No abstract available.

3.

Prognostic value of multiple biomarkers in American Indians free of clinically overt cardiovascular disease (from the Strong Heart Study).

Kizer JR, Krauser DG, Rodeheffer RJ, Burnett JC Jr, Okin PM, Roman MJ, Umans JG, Best LG, Lee ET, Devereux RB.

Am J Cardiol. 2009 Jul 15;104(2):247-53. doi: 10.1016/j.amjcard.2009.03.026. Epub 2009 Jun 3.

4.

Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).

Brettschneider C, L├╝hmann D, Raspe H.

GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092.

5.

ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures.

Bonow RO, Douglas PS, Buxton AE, Cohen DJ, Curtis JP, Delong E, Drozda JP Jr, Ferguson TB Jr, Heidenreich PA, Hendel RC, Masoudi FA, Peterson ED, Taylor AJ.

J Am Coll Cardiol. 2011 Sep 27;58(14):1517-38. doi: 10.1016/j.jacc.2011.07.007. Epub 2011 Aug 29.

6.

Critical appraisal of inflammatory markers in cardiovascular risk stratification.

Krintus M, Kozinski M, Kubica J, Sypniewska G.

Crit Rev Clin Lab Sci. 2014 Oct;51(5):263-79. doi: 10.3109/10408363.2014.913549. Epub 2014 Jun 11. Review.

PMID:
24918900
7.

Evaluating the prognostic value of new cardiovascular biomarkers.

Wood AM, Greenland P.

Dis Markers. 2009;26(5-6):199-207. doi: 10.3233/DMA-2009-0631. Review.

8.

Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques.

Zannad F, De Backer G, Graham I, Lorenz M, Mancia G, Morrow DA, Reiner Z, Koenig W, Dallongeville J, Macfadyen RJ, Ruilope LM, Wilhelmsen L; ESC Working Group on CardioVascular Pharmacology and Drug Therapy..

Fundam Clin Pharmacol. 2012 Apr;26(2):163-74. doi: 10.1111/j.1472-8206.2011.01023.x. Epub 2012 Jan 5. Review.

PMID:
22220636
9.

Subgroup specific incremental value of new markers for risk prediction.

Zhou QM, Zheng Y, Cai T.

Lifetime Data Anal. 2013 Apr;19(2):142-69. doi: 10.1007/s10985-012-9235-3. Epub 2012 Dec 23.

10.

American Medical Society for Sports Medicine position statement: concussion in sport.

Harmon KG, Drezner JA, Gammons M, Guskiewicz KM, Halstead M, Herring SA, Kutcher JS, Pana A, Putukian M, Roberts WO.

Br J Sports Med. 2013 Jan;47(1):15-26. doi: 10.1136/bjsports-2012-091941. Review. Erratum in: Br J Sports Med. 2013 Feb;47(3):184.

PMID:
23243113
11.

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines..

Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73. doi: 10.1161/01.cir.0000437741.48606.98. Epub 2013 Nov 12. No abstract available. Erratum in: Circulation. 2014 Jun 24;129(25 Suppl 2):S74-5.

12.

Current concepts of tumor markers in bladder cancer.

Droller MJ.

Urol Clin North Am. 2002 Feb;29(1):229-34. Review.

PMID:
12109349
13.

Effectiveness of programmes as part of primary prevention demonstrated on the example of cardiovascular diseases and the metabolic syndrome.

Korczak D, Dietl M, Steinhauser G.

GMS Health Technol Assess. 2011 Apr 1;7:Doc02. doi: 10.3205/hta000093.

14.

New blood test to measure heart attack risk: C-reactive protein.

Duffy JR, Salerno M.

J Cardiovasc Nurs. 2004 Nov-Dec;19(6):425-9. Review.

PMID:
15529066
15.

The Omega-3 Index as a risk factor for cardiovascular diseases.

von Schacky C.

Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):94-8. doi: 10.1016/j.prostaglandins.2011.06.008. Epub 2011 Jun 24. Review.

PMID:
21726658
16.

C-reactive protein: a new risk assessment tool for cardiovascular disease.

Clearfield MB.

J Am Osteopath Assoc. 2005 Sep;105(9):409-16. Review.

PMID:
16239491
17.

Do novel biomarkers add to existing scores of total cardiovascular risk?

De Backer G, Graham I, Cooney MT.

Eur J Prev Cardiol. 2012 Aug;19(2 Suppl):14-7. doi: 10.1177/2047487312448988. Review.

PMID:
22801065
18.

Standards for measures used for public reporting of efficiency in health care: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes research and the American College of Cardiology Foundation.

Krumholz HM, Keenan PS, Brush JE Jr, Bufalino VJ, Chernew ME, Epstein AJ, Heidenreich PA, Ho V, Masoudi FA, Matchar DB, Normand SL, Rumsfeld JS, Schuur JD, Smith SC Jr, Spertus JA, Walsh MN; American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research.; American College of Cardiology Foundation..

J Am Coll Cardiol. 2008 Oct 28;52(18):1518-26. doi: 10.1016/j.jacc.2008.09.004.

19.

ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures.

Bonow RO, Douglas PS, Buxton AE, Cohen DJ, Curtis JP, Delong E, Drozda JP Jr, Ferguson TB Jr, Heidenreich PA, Hendel RC, Masoudi FA, Peterson ED, Taylor AJ; American College of Cardiology Foundation.; American Heart Association Task Force on Performance Measures..

Circulation. 2011 Sep 27;124(13):1483-502. doi: 10.1161/CIR.0b013e31822935fc. Epub 2011 Aug 29.

20.

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK; American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research, and the American Diabetes Association..

Circulation. 2015 Aug 25;132(8):691-718. doi: 10.1161/CIR.0000000000000230. Epub 2015 Aug 5. Review.

Supplemental Content

Support Center